These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 36360668)
21. [Monkeypox, a new pandemic?]. de Stoppelaar SF; Hoornenborg E; van Rijckevorsel G; Vollaard A; Brandwagt DAH; de Vries HJC; Schinkel J; Welkers MRA; Goorhuis A Ned Tijdschr Geneeskd; 2022 Sep; 166():. PubMed ID: 36300487 [TBL] [Abstract][Full Text] [Related]
22. Short-term impact of the Covid-19 pandemic on the global and Turkish economy. Açikgöz Ö; Günay A Turk J Med Sci; 2021 Dec; 51(SI-1):3182-3193. PubMed ID: 34365782 [TBL] [Abstract][Full Text] [Related]
23. Validation Study of a Direct Real-Time PCR Protocol for Detection of Monkeypox Virus. Chelsky ZL; Dittmann D; Blanke T; Chang M; Vormittag-Nocito E; Jennings LJ J Mol Diagn; 2022 Nov; 24(11):1155-1159. PubMed ID: 36113759 [TBL] [Abstract][Full Text] [Related]
24. Monkeypox: what do dental professionals need to know? Zemouri C; Beltrán EO; Holliday R; Jakubovics NS; Allison JR Br Dent J; 2022 Oct; 233(7):569-574. PubMed ID: 36241815 [TBL] [Abstract][Full Text] [Related]
25. Monkeypox virus vaccine evolution and global preparedness for vaccination. Chakraborty C; Bhattacharya M; Ranjan Sharma A; Dhama K Int Immunopharmacol; 2022 Dec; 113(Pt A):109346. PubMed ID: 36274490 [TBL] [Abstract][Full Text] [Related]
26. In Silico Repurposed Drugs against Monkeypox Virus. Lam HYI; Guan JS; Mu Y Molecules; 2022 Aug; 27(16):. PubMed ID: 36014515 [TBL] [Abstract][Full Text] [Related]
28. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries. Obeng-Kusi M; Habila MA; Roe DJ; Erstad B; Abraham I J Med Econ; 2021 Nov; 24(sup1):1-13. PubMed ID: 34866541 [TBL] [Abstract][Full Text] [Related]
29. Labour productivity and economic impacts of carbon mitigation: a modelling study and benefit-cost analysis. Zhao M; Huang X; Kjellstrom T; Lee JKW; Otto M; Zhang X; Romanello M; Zhang D; Cai W Lancet Planet Health; 2022 Dec; 6(12):e941-e948. PubMed ID: 36495888 [TBL] [Abstract][Full Text] [Related]
30. Dynamical analysis of monkeypox transmission incorporating optimal vaccination and treatment with cost-effectiveness. Majee S; Jana S; Kar TK Chaos; 2023 Apr; 33(4):. PubMed ID: 37097947 [TBL] [Abstract][Full Text] [Related]
31. Economic burden of out-of-pocket expenditure, productivity cost during pregnancy and COVID-19 impact on household economy in a cohort of pregnant women in Anuradhapura District, Sri Lanka; A study protocol. Gunarathne SP; Wickramasinghe ND; Agampodi TC; Prasanna IR; Agampodi SB F1000Res; 2021; 10():700. PubMed ID: 35528955 [No Abstract] [Full Text] [Related]
32. Temporal dynamic characteristics of human monkeypox epidemic in 2022 around the world under the COVID-19 pandemic background. Cao Y; Li M; Haihambo N; Wang X; Zhao X; Wang B; Sun M; Guo M; Han C Front Public Health; 2023; 11():1120470. PubMed ID: 36778555 [TBL] [Abstract][Full Text] [Related]
33. The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review. Antwi F; Fazylova N; Garcon MC; Lopez L; Rubiano R; Slyer JT JBI Libr Syst Rev; 2012; 10(42 Suppl):1-14. PubMed ID: 27820152 [TBL] [Abstract][Full Text] [Related]
34. Indirect COVID-19 health effects and potential mitigating interventions: Cost-effectiveness framework. Maya S; Kahn JG; Lin TK; Jacobs LM; Schmidt LA; Burrough WB; Ghasemzadeh R; Mousli L; Allan M; Donovan M; Barker E; Horvath H; Spetz J; Brindis CD; Malekinejad M PLoS One; 2022; 17(7):e0271523. PubMed ID: 35849613 [TBL] [Abstract][Full Text] [Related]
35. Public health and social measures to mitigate the health and economic impact of the COVID-19 pandemic in Turkey, Egypt, Ukraine, Kazakhstan, and Poland during 2020-2021: situational analysis. Kitamura N; Abbas K; Nathwani D BMC Public Health; 2022 May; 22(1):991. PubMed ID: 35578330 [TBL] [Abstract][Full Text] [Related]
36. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Yinka-Ogunleye A; Aruna O; Dalhat M; Ogoina D; McCollum A; Disu Y; Mamadu I; Akinpelu A; Ahmad A; Burga J; Ndoreraho A; Nkunzimana E; Manneh L; Mohammed A; Adeoye O; Tom-Aba D; Silenou B; Ipadeola O; Saleh M; Adeyemo A; Nwadiutor I; Aworabhi N; Uke P; John D; Wakama P; Reynolds M; Mauldin MR; Doty J; Wilkins K; Musa J; Khalakdina A; Adedeji A; Mba N; Ojo O; Krause G; Ihekweazu C; Lancet Infect Dis; 2019 Aug; 19(8):872-879. PubMed ID: 31285143 [TBL] [Abstract][Full Text] [Related]
37. A general framework for optimising cost-effectiveness of pandemic response under partial intervention measures. Nguyen QD; Prokopenko M Sci Rep; 2022 Nov; 12(1):19482. PubMed ID: 36376551 [TBL] [Abstract][Full Text] [Related]
38. Atypical and Unique Transmission of Monkeypox Virus during the 2022 Outbreak: An Overview of the Current State of Knowledge. Riopelle JC; Munster VJ; Port JR Viruses; 2022 Sep; 14(9):. PubMed ID: 36146818 [TBL] [Abstract][Full Text] [Related]
39. Healthcare workers and monkeypox: The case for risk mitigation. Manirambona E; Felicilda Lopez JC; Nduwimana C; Okesanya OJ; Mbonimpaye R; Musa SS; Usman AH; Lucero-Prisno DE Int J Surg Open; 2023 Jan; 50():100584. PubMed ID: 36573201 [TBL] [Abstract][Full Text] [Related]